Cholesterol-lowering drugs called statins have the potential to reduce heart disease in people with obstructive sleep apnea regardless of CPAP use, suggests a new study from Columbia University.
After a sudden medical scare, many people develop a fear of health care and are afraid to adopt new health habits. The Center for Fearless Behavior Change is testing ways to help.
Iok In Christine Chio, PhD, and Oliver Clarke, PhD, early-career investigators at VP&S, are 2023 recipients of prestigious awards from the Irma T. Hirschl Trust Research Scientist Program.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
An experimental gene therapy for sickle cell disease restored blood cells to their normal shape and eliminated severe pain crises for years after treatment, a multicenter study has found.
Six scientists at Columbia have received NIH “High-Risk” grants that support exceptionally creative scientists and unconventional approaches to solving major challenges in medicine.
The grant to the Vagelos College of Physicians and Surgeons will help medical researchers speed the application of scientific discoveries, so that new treatments can be delivered to patients faster.
Wang received the prize, awarded annually to immigrants whose work demonstrates exceptional insight or innovation, for his development of synthetic biology tools.
With $10 million from Pfizer, the Initiative aims to increase the participation of underrepresented minorities in clinical trials and enhance the diversity of clinical researchers.